NDRA logo

ENDRA Life Sciences (NDRA) News & Sentiment

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
NDRA
businesswire.comNovember 15, 2024

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ended September 30, 2024 and provided a business update. Highlights from the third quarter and recent weeks include: Developed data analysis features for TAEUS platform by introducing new models rooted in artificial intelligence (AI), machine learning (ML) and deep learning (DL). As part of its conti.

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
NDRA
seekingalpha.comAugust 22, 2024

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2024 Earnings Conference Call August 22, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Alexander Tokman - Acting CEO Ziad Rouag - Head of Regulatory and Clinical Affairs Michael Thornton - Chief Technology Officer Richard Jacroux - CFO Conference Call Participants Edward Woo - Ascendiant Capital Operator Good afternoon, and welcome to the ENDRA Life Sciences Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
NDRA
businesswire.comJune 4, 2024

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is a best-efforts offering, with no minimum amount of securities required to be sold. The offering is.

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit
AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit
AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit
NDRA
businesswire.comJune 4, 2024

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best will host a complimentary webinar titled “The Case for Engaging Defense Counsel Pre-Lawsuit,” on June 25, 2024, at 2:00 p.m. ET. In this webinar, sponsored by Three Griffins, Inc., a panel of insurance claims experts will examine the path from claim to lawsuit, and best practices on minimizing loss through appropriate legal consultation. Register now. Panelists include: Daniel Herbert, president/CEO, Three Griffins, Inc. Donald J. Richardson, shareholder,.

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript
NDRA
Seeking AlphaMay 14, 2024

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2024 Earnings Call Transcript May 14, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and CEO Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Welcome to the ENDRA Life Sciences First Quarter 2024 Financial Results Conference call. All participants will be in a listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
NDRA
Seeking AlphaMarch 28, 2024

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript
NDRA
Seeking AlphaNovember 14, 2023

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2023 Results Conference Call November 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript
NDRA
Seeking AlphaAugust 14, 2023

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript
NDRA
Seeking AlphaMay 15, 2023

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Inc. First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.